Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.49 |
| ▸ | CBX7 | O95931 | 1/20 | 0.43 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.43 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.43 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25865302 | 0.90 | TSPO (0.49) | TSPO | |
| SCHEMBL25869117 | 0.88 | TSPO (0.52) | TSPOCBX7CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL20471932 | 0.84 | TSPO (0.48) | TSPO | |
| SCHEMBL27033665 | 0.81 | CDYL2 (0.63) | TSPOCBX7CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL31324857 | 0.81 | CDYL2 (0.63) | TSPOCBX7CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL25868217 | 0.80 | MAPT (0.46) | TSPO | |
| SCHEMBL25865325 | 0.80 | KMO (0.49) | TSPO | |
| SCHEMBL16186523 | 0.78 | IDO1 (0.62) | — | |
| SCHEMBL30660243 | 0.78 | CBX7 (0.54) | CBX7CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL20472305 | 0.78 | CBX7 (0.54) | CBX7CDYL2CDYLCDY1; CDY1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219938-A1 | COMPOUNDS AND THEIR METHODS OF USE | PRAXIS PREC MEDICINES INC (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219938-A1 | COMPOUNDS AND THEIR METHODS OF USE | SCN1A, SCN3A, SCN1B | TSPO 394/4885CBX7 1133/4885CDYL2 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.